rs2069453

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_004935.4(CDK5):​c.313-326C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 506,930 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0028 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00045 ( 1 hom. )

Consequence

CDK5
NM_004935.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.74

Publications

2 publications found
Variant links:
Genes affected
CDK5 (HGNC:1774): (cyclin dependent kinase 5) This gene encodes a proline-directed serine/threonine kinase that is a member of the cyclin-dependent kinase family of proteins. Unlike other members of the family, the protein encoded by this gene does not directly control cell cycle regulation. Instead the protein, which is predominantly expressed at high levels in mammalian postmitotic central nervous system neurons, functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. In humans, an allelic variant of the gene that results in undetectable levels of the protein has been associated with lethal autosomal recessive lissencephaly-7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]
CDK5 Gene-Disease associations (from GenCC):
  • lissencephaly 7 with cerebellar hypoplasia
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK5NM_004935.4 linkc.313-326C>T intron_variant Intron 5 of 11 ENST00000485972.6 NP_004926.1 Q00535-1A0A090N7W4
CDK5NM_001164410.3 linkc.312+406C>T intron_variant Intron 5 of 10 NP_001157882.1 Q00535-2A0A0S2Z355

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK5ENST00000485972.6 linkc.313-326C>T intron_variant Intron 5 of 11 1 NM_004935.4 ENSP00000419782.1 Q00535-1
CDK5ENST00000297518.4 linkc.312+406C>T intron_variant Intron 5 of 10 1 ENSP00000297518.4 Q00535-2
CDK5ENST00000476691.1 linkn.187C>T non_coding_transcript_exon_variant Exon 1 of 2 4
CDK5ENST00000487703.5 linkn.677-326C>T intron_variant Intron 5 of 7 5

Frequencies

GnomAD3 genomes
AF:
0.00285
AC:
434
AN:
152124
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00988
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00239
GnomAD4 exome
AF:
0.000451
AC:
160
AN:
354688
Hom.:
1
Cov.:
0
AF XY:
0.000385
AC XY:
71
AN XY:
184494
show subpopulations
African (AFR)
AF:
0.0105
AC:
116
AN:
11042
American (AMR)
AF:
0.000646
AC:
9
AN:
13934
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11516
East Asian (EAS)
AF:
0.0000772
AC:
2
AN:
25918
South Asian (SAS)
AF:
0.0000629
AC:
2
AN:
31804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
22928
Middle Eastern (MID)
AF:
0.000619
AC:
1
AN:
1616
European-Non Finnish (NFE)
AF:
0.0000885
AC:
19
AN:
214598
Other (OTH)
AF:
0.000516
AC:
11
AN:
21332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00284
AC:
433
AN:
152242
Hom.:
2
Cov.:
33
AF XY:
0.00270
AC XY:
201
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.00983
AC:
408
AN:
41518
American (AMR)
AF:
0.000785
AC:
12
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68028
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
25
49
74
98
123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00105
Hom.:
1
Bravo
AF:
0.00331
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.014
DANN
Benign
0.61
PhyloP100
-2.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2069453; hg19: chr7-150753261; API